Joy at Egetis after positive CHMP opinion – ”The single most important milestone”

Stockholm-based Egetis Therapeutics has received a positive CHMP opinion for Emcitate, which could become the first approved treatment for the rare disease MCT8 deficiency."

Clean solutions - Handling viscose substances with precision

Laboratories in the chemical, petrochemical, pharmaceutical and food technology industries are increasingly relying on automation for sample preparation. The Mo...

ZEISS Lightfield 4D for instant volumetric high-speed imaging

Capturing physiological and neuronal processes in 3D.

“We aim to be a start-up company with an academic spirit”

Chronic pain and Alzheimer’s are two diseases that plague many people worldwide and seem impossible to cure. However, Huddinge-based company Alzecure is working...

Lösning för inspektion av cylindriska och långa objekt

Vissa inspektioner är svåra att utföra med traditionella visionsystem. Till exempel kan det vara utmanande att inspektera cylindriska objekt eller extremt långa...

Precision and accuracy in liquid handling

How to evaluate and optimize liquid handling performance

The new ZEISS Celldiscoverer 7 has been launched

Adaptable automation for advanced workflows.

BioArctic moves forward with its candidate for Parkinson’s

BioArctic announces positive early phase study results for its drug candidate for Parkinson’s disease.

Save time and money !

Festo Digital engineering tools helps you to calculate the most cost and efficient solution for your application for free

Sobi announces agreement with Enable Injections

Swedish biopharma Sobi has entered into an international development and distribution agreement with US drug delivery company Enable Injections.

Great Swedish innovations: Eye treatment became a feather in Pharmacia’s cap

From complicated and sometimes risky surgery to a routine procedure. Pharmacia’s injectable Healon revolutionised the field of eye surgery - and is considered b...

CAR-T therapies give continued hope: “Almost half of the patients have become disease-free”

become disease-free, at least of those treated with Yescarta, which are the ones I know best,” says Gunilla Enblad, Chairman of the national working group for CAR-T treatment.

We will now publish more news in English – and offer yet another newsletter

Starting next week, Life Science Sweden will begin offering a newsletter entirely in English.

CTC Clinical Trial Consultants AB

Carl Zeiss AB

Han är ny på Sahlgrenska Science Park

Mats Hellström är Sahlgrenska Science Parks nya Lab Manager. I hans nya roll ska han se över satsningen Health Innovation Labs.

SupraCube - In life Science

Superconductors must be permanently kept below their transition temperature for levitation. Because of the integrated cooler, applications with superconductors ...

A vaccine the world is waiting for: “It can change the lives of many”

A Solna laboratory is developing a vaccine that could save the lives of countless children in low- and middle-income countries. “Working on something that can m...

Automated dispensing

Are you interested in automated dispensing of liquids?

Logistiklösningar?

Hos OEM Automatic hittar du både produkter och expertis under ett och samma tak. Med vår omfattande och mångsidiga produktportfölj får du tillgång till ett bret...

Security flaw in Swedish breast cancer screening software – woman passed away

A lack of safeguard in Sectra's software led to a woman with breast cancer receiving an incorrect diagnosis. She later passed away. The software is used in 20 o...

SMC lanserar världens smalaste magnetventil

Med robot-integratörer och maskinbyggare i åtanke lanserar SMC världens smalaste magnetventil. JSY:s låga vikt och små byggmått sparar energi/plats i rörliga ap...

Hemarbete ökar risken för nätfiske i läkemedelsföretag

Allt fler hackerförsök inom läkemedelsbranschen riktar sig mot anställdas mobiltelefoner.

Carl Borrebaeck – professor and serial entrepreneur with a taste for speed

Award-winning cancer researcher, the founder of many listed companies, and constantly in the academic and commercial spotlight for decades. However, Carl Borreb...